Please assess the completion status of the following clinical trial:

Trial Title: Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* is at least 22 years of age on the date of informed consent.~* can independently provide informed consent.~* requires and is scheduled to undergo a simultaneous, bilateral, primary TKA.~* is willing and physically capable of undergoing a simultaneous, bilateral, primary TKA with or without replacement of the patella.~* is willing and able to return for all scheduled study visits.~Exclusion Criteria:~* is pregnant or lactating.~* has signs of an infection in the area of either knee or has signs of a systemic infection at the time of surgery.~* is a chronic opioid user, defined per the CDC guidelines as opioid use for \>3 months, at the time of enrollment.~* has a current diagnosis of lymphedema in either leg.~* has signs, symptoms, or a current diagnosis of venous insufficiency in either leg, as determined by the investigator's review of the subject's medical history.~* has a history of clotting disorder or prior history of deep vein thrombosis~* will undergo a unilateral TKA.~* will undergo a staged, bilateral TKA.~* has had previous knee replacement surgery.~* has received a corticosteroid injection into either knee within 30 days of surgery.~* undergoes a simultaneous, bilateral TKA with a planned different incision type on each knee (eg, midline incision vs. medial parapatellar incision).~* has known sensitivity to the study product components (drape and/or dressing materials in direct contact with the closed incision or skin).~* has known sensitivity to silver.~* is enrolled in another interventional clinical study.~* has skin cancer localized at or in proximity to the incision site.~* does not have access to an electronic device (smartphone, iPad, or computer) on a daily basis to complete online assessments.~* has condition(s) that, in the opinion of the investigator, cause the subject to be an overall health risk that is unsuitable for the surgery.~* has condition(s) that, in the opinion of the investigator, will impact study endpoints (eg, hemophilia or autoimmune disorders) or the ability to comply with study procedures.~Intra-Op Exclusion Criteria:~* does not receive a total knee replacement for first knee. For example, a partial or uni-compartmental knee replacement is performed~* has a surgical incision that would preclude placement of either dressing onto the knee~* has a TKA resulting in a muscle flap

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Closed Incision Negative Pressure Therapy (ciNPT) Dressing (Type: EXPERIMENTAL): Prevena Restor Arthro-Form Dressing with Prevena Plus Therapy Unit
- Standard Silver-containing Dressing (Type: ACTIVE_COMPARATOR): Standard silver dressing - standard of care at hospital

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues